News

Fierce Pharma40m
With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs
In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...
inews.co.uk on MSN55m
GPs swamped by requests for NHS Mounjaro - but no one qualifies
Thousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
Stung by high prices, Americans make their own weight-loss drugs
By Robin Respaut and Maggie Fick SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, ...
inews.co.uk on MSN55m
GPs swamped by requests for NHS Mounjaro – but hardly anyone qualifies
Thousands are inundating GP surgeries for the weight loss jab – but even those who meet the criteria could face a wait of ...